Groundbreaking human trials begin for spider venom-derived drug Researchers in Australia have launched a first-in-human trial of a novel drug derived from the venom of one of the world’s most dangerous spiders. The Phase 1 study aims to evaluate safety, tolerability, and preliminary signals of efficacy for a treatment that could transform responses to heart…